Pharmaceutical Biotechnology

This specialization covers biologically derived medicines: recombinant therapeutic proteins, monoclonal antibodies, vaccines including recombinant and mRNA platforms, and cell and gene therapy. Expect mammalian cell culture upstream, chromatographic purification downstream, formulation and stability, bioanalytical characterisation and potency assay, and the regulatory path from preclinical work through clinical phases, with biosimilars and quality-by-design as recurring themes.